Organon & Co. - stock earnings
OGN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 546.0 million USD | 1.6 billion USD |
| 2023Q3 | 58.0 million USD | 1.5 billion USD |
| 2023Q2 | 242.0 million USD | 1.6 billion USD |
| 2023Q1 | 177.0 million USD | 1.5 billion USD |
| 2022Q4 | 108.0 million USD | 1.5 billion USD |
| 2022Q3 | 227.0 million USD | 1.5 billion USD |
| 2022Q2 | 234.0 million USD | 1.6 billion USD |
| 2022Q1 | 348.0 million USD | 1.6 billion USD |
| 2021Q4 | 202.0 million USD | 1.6 billion USD |
| 2021Q3 | 323.0 million USD | 1.6 billion USD |
| 2021Q2 | 427.0 million USD | 1.6 billion USD |
| 2021Q1 | 399.0 million USD | 1.5 billion USD |
| 2020Q4 | 368.0 million USD | 3.2 billion USD |
| 2020Q3 | 547.0 million USD | 1.6 billion USD |
| 2020Q2 | 542.0 million USD | 1.5 billion USD |
| 2020Q1 | 703.0 million USD | 1.8 billion USD |
OGN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 1.0 billion USD | 6.3 billion USD |
| 2022 | 917.0 million USD | 6.2 billion USD |
| 2021 | 1.4 billion USD | 6.3 billion USD |
| 2020 | 2.2 billion USD | 8.1 billion USD |
| 2019 | 3.2 billion USD | 7.8 billion USD |
| 2018 | 2.2 billion USD | 9.8 billion USD |
| 2017 | 1.8 billion USD | 10.5 billion USD |
OGN
Price: $18.55
Dividend Yield: 0.06%
Forward Dividend Yield: 6.04%
Payout Ratio: 49.12%
Dividend Per Share: 1.12 USD
Earnings Per Share: 3.99 USD
P/E Ratio: 7.18
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 1.6 million
Market Capitalization: 4.6 billion
Average Dividend Frequency: 4
Years Paying Dividends: 4